资讯
News-Medical.Net on MSN
GLP-1 drugs may offer cost-effective treatment for people with knee osteoarthritis and obesity
A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for ...
Tirzepatide is more cost-effective than semaglutide for knee osteoarthritis and obesity, optimizing resources for patients ...
Analysis led by Mass General Brigham researchers shows tirzepatide offers greater value than semaglutide for most patients• For eligible and willing ...
Joe Burrow's toe injury has the Bengals reportedly consulting a foot specialist about possible surgery that could keep the ...
A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for ...
Kansas City Chiefs coach Andy Reid said Xavier Worthy isn't currently considering undergoing surgery on the shoulder injury ...
Manly owner Scott Penn says the club is ready to fight for Tom Trbojevic amid shock reports out of England that he is being ...
Knee pain affects 25% of adults, and doctors say surgery isn’t always first. Options include medication, injections, therapy, ...
Varian, a Siemens Healthineers company, announced today that its Embozene microspheres have received CE Marking for Genicular Artery Embolisation (GAE) for knee osteoarthritis. This regulatory ...
Doctors say there are several ways to manage knee pain from osteoarthritis before considering replacement surgery.
From the time Ryan Bliss underwent surgery to repair his torn biceps, the focus was always on beating the timeline for his recovery and possibly being an option for the Mariners before the end of the ...
After a tumultuous, injury-plagued 2024-25 campaign in which the Philadelphia 76ers went 24-58, there's still a question on ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果